Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,624 across all filing types
Latest filing 2023-12-11 Proxy Solicitation & In…
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
PROXY FORM FOR USE AT THE 2023 SECOND EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proxy form for the 2023 second extraordinary general meeting of RemeGen Co., Ltd. It includes instructions for shareholders to appoint proxies to vote on various resolutions at the meeting, including changes to projects, approval of a restricted share incentive scheme, amendments to articles of association, and internal management systems. The content is procedural and related to voting instructions rather than the results of the vote or the meeting itself. It is not a report or announcement of voting results but a solicitation for proxy votes. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length (7,725 characters) and detailed voting instructions support this classification with high confidence.
2023-12-11 English
NOTICE OF 2023 FIRST CLASS MEETING OF H SHAREHOLDERS
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a notice for a 2023 first class meeting of H shareholders of RemeGen Co., Ltd. It includes details about the meeting date, location, agenda items (special resolutions), proxy voting instructions, and shareholder eligibility. The document is a formal announcement inviting shareholders to attend and vote on specific resolutions related to the company's restricted share incentive scheme. It does not contain financial statements, management discussion, or detailed financial data. It is not a report itself but a notice of a shareholder meeting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2023-12-11 English
NOTICE OF 2023 SECOND EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice for the 2023 second extraordinary general meeting (EGM) of RemeGen Co., Ltd. It includes details about the meeting date, location, agenda items (resolutions to be considered and approved), proxy voting instructions, and other procedural notes. There are no financial statements, management discussion, or detailed financial data presented. The document serves as an announcement to shareholders about the upcoming EGM and the matters to be voted on, rather than the results of the meeting or the full report itself. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2023-12-11 English
2023 SECOND EXTRAORDINARY GENERAL MEETING CIRCULAR
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from RemeGen Co., Ltd. concerning the proposed adoption of a 2023 A Share Incentive Scheme, amendments to articles of association, rules of procedures for shareholders meetings, board of directors, supervisory committee, and other governance-related matters. It also includes notices for an Extraordinary General Meeting (EGM) and class meetings of shareholders. The document contains detailed appendices and definitions related to governance and shareholder meetings. The presence of proxy forms and detailed meeting notices indicates this is a solicitation and information circular for shareholder meetings rather than the meeting itself or voting results. The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or a brief notice. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides information to shareholders to request votes for meetings. It is not an Annual Report, Board/Management change announcement, nor a Voting Results declaration. Therefore, the appropriate classification is PSI with high confidence.
2023-12-11 English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE UNDER THE BOARD OF THE COMPANY
Governance Information Classification · 95% confidence The document is titled 'Terms of Reference of the Nomination Committee under the Board of the Company' and details the structure, duties, responsibilities, composition, powers, and procedural rules of the Nomination Committee. It references corporate governance codes, board composition, director nomination and appointment processes, and compliance with listing rules. There is no financial data, earnings information, or report publication announcement. The content is focused on governance practices and board/management structure rather than financial results or shareholder voting outcomes. Therefore, the document fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-12-07 English
TERMS OF REFERENCE OF THE REMUNERATION AND APPRAISAL COMMITTEE UNDER THE BOARD OF THE COMPANY
Remuneration Information Classification · 95% confidence The document is titled 'TERMS OF REFERENCE OF THE REMUNERATION AND APPRAISAL COMMITTEE UNDER THE BOARD OF THE COMPANY' and details the structure, duties, responsibilities, and procedures of the Remuneration and Appraisal Committee. It references compliance with the Listing Rules on The Stock Exchange of Hong Kong Limited and discusses remuneration policies, appraisal standards, and governance related to directors and senior management compensation. There is no financial data, earnings information, or report publication announcement. The content is focused on remuneration governance and committee terms of reference, which aligns with the definition of Remuneration Information filings.
2023-12-07 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.